Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Rare Cancers, Early Phase Trials

Tobias Arkenau

MD, PhD

🏢START London / Sarah Cannon Research Institute🌐UK

Director, The NIHR Clinical Research Facility / Global Medical Director

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Tobias Arkenau is a prominent early-phase oncology investigator specializing in rare and hard-to-treat cancers. He has been a lead investigator in multiple first-in-human and basket trials for rare tumor types and is recognized for developing innovative clinical trial designs for rare cancers. His work has advanced tissue-agnostic and biomarker-driven approaches that have particular utility for rare malignancies.

Share:

🧪Research Fields 研究领域

rare cancer drug development
early phase oncology trials
biomarker-driven rare tumor therapy
basket trials rare cancers
agnostic cancer therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Tobias Arkenau 的研究动态

Follow Tobias Arkenau's research updates

留下邮箱,当我们发布与 Tobias Arkenau(START London / Sarah Cannon Research Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment